USAID to cut most staff; Musk’s buyout deadline delayed, and more
The World in Brief from The Economist
The Economist
4.1 • 1.2K Ratings
🗓️ 7 February 2025
⏱️ 6 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Hello, you're listening to the free edition of the world in brief from The Economist. |
| 0:11.2 | As a reminder, if you subscribe to The Economist, you'll get access to a deeper look at the day ahead, updated three times a day. |
| 0:20.1 | If you're already an Economist subscriber, visit |
| 0:22.9 | economist.com slash espresso or visit our espresso app to start listening. Here's today's |
| 0:29.5 | free edition. |
| 0:35.3 | This is the world in brief from The Economist. |
| 0:42.3 | Our top stories. |
| 0:45.3 | Donald Trump's administration will reportedly slash the workforce of USAID, America's main development agency, from 10,000 to less than 300. The news of the expected cuts |
| 0:58.6 | comes a day before most of the agency's employees are to be placed on administrative leave. |
| 1:05.1 | Marco Rubio, the Secretary of State, who on Monday assumed the title of USAID's acting director, said |
| 1:13.0 | rank insubordination within the agency necessitated the takeover. |
| 1:18.8 | A judge delayed the deadline for American federal workers to respond to a buyout offer from |
| 1:25.4 | Thursday to at least Monday. The deferred resignation scheme, |
| 1:30.3 | devised by Elon Musk and his Department of Government Efficiency, would allow employees who quit |
| 1:36.7 | to be paid until September. The Washington Post reported that less than 2% of the federal |
| 1:42.7 | workforce, despite being pressured to accept the |
| 1:45.9 | deal, had done so as of Wednesday. The Bank of England cut interest rates by 0.25 percentage |
| 1:54.3 | points to 4.5% its third reduction since August 24. Guilt yields fell on the news. |
| 2:03.0 | The Futsi 100 hit a record high ahead of the decision, |
| 2:07.3 | driven by expectations of lower borrowing costs. |
| 2:11.1 | Strong corporate earnings also lifted stocks, |
| 2:13.8 | with AstraZeneca's share price rising nearly 5% after posting better than expected results. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Economist, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Economist and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

